One of Monte Rosa Therapeutics' main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders. This process also leverages AI. They now have two important ...

MILAN, ITALY - JANUARY 26: Fans of AC Milan look on during the Serie A match between AC Milan and Parma at Stadio Giuseppe Meazza on January 26, 2025 in Milan, Italy. (Photo by Marco Luzzani/Getty ...

MILAN, Italy -- Who knows exactly what thoughts lurked inside the head of Theo Hernández, just beneath his shocking pink tufts of hair, when he made the most boneheaded of decisions five minutes ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

AC Milan have signed Mexican forward Santiago Gimenez from Feyenoord on a four-and-a-half-year deal, the Serie A club said on Monday. Gimenez, who was born in Argentina but is a Mexican citizen ...

The northern city of Milan is a gateway to a number of European destinations, with trains leaving from its bustling Centrale station and reaching four other countries. One advantage of living in Milan ...

Milan have reached a verbal agreement for the loan signing of Joao Felix from Chelsea. Milan are set to cover the 25-year-old’s full salary as part of a straight loan deal without a buy option ...

A goalkeeping howler handed Feyenoord a 1-0 home win over AC Milan in an action-packed first leg of their Champions League knockout phase playoff tie on Wednesday, just two days after the Dutch ...

Milan defender Fikayo Tomori insists he never thought about leaving the club in January and feels he and his teammates ‘know exactly’ what to do to beat Feyenoord tomorrow. The Rossoneri will ...

Image: Chelsea have agreed a deal to sell Joao Felix to AC Milan AC Milan have agreed in principle to take Chelsea's Joao Felix on loan for the rest of the season. Chelsea are set to receive a £ ...

Bailed-out lender Monte dei Paschi di Siena has today launched ... MPS, which aims at delisting Mediobanca's shares from the Milan bourse, estimated pre-tax benefits of €700m a year from the ...

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...